On December 7, 2020, Qualigen Therapeutics, Inc.'s Board of Directors appointed Sidney Emery, Jr. as a member of the Board, to fill a vacant seat on the Board. The Board has determined that Mr. Emery is an independent director under applicable rules of the Securities and Exchange Commission and the Nasdaq Stock Market LLC. Mr. Emery has been named to serve on the following committees of Board: Nominating and Corporate Governance Committee (chair), Audit Committee and Compensation Committee.